Clinical study on vyanga w.s.r to melasma

A comparative clinical evaluation of jatiphala(myristica frangans.Houtt.) bheejakosha lepa and ushira (vetiveria zizanioides linn) moola lepa in vyanga w.s.r to melasma. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060373

Enrollment

Registered

2023-11-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects having classical symptoms of Vyanga will be selected randomly irrespective of gender for the study.

Exclusion criteria

Exclusion criteria: Pregnant women, nursing mothers. Subjects suffering from other pigmentation disorders like vitiligo, Pityriasis Alba etc Subjects who have used any cosmetic depigmenting agent within 2 weeks prior to inclusion.

Design outcomes

Primary

Measure	Time frame
Decreases the Hyper Pigmentation on Face.Timepoint: 4 Weeks.	—

Secondary

Measure	Time frame
Decrease of Circular Patches on Face.Timepoint: 2 weeks..	—

Countries

India

Contacts

Public ContactDr M S Veena

Government Ayurveda Medical College Bengalore 560009 Dhanvantari road

yogesh10660@gmail.com9739765632

Outcome results